Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lee Cranmer
A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study
Oncotarget
Oncology
Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
Treatment With Tumour Infiltrating Lymphocytes and Interleukin-2 in Patients With Metastatic Melanoma: A Pilot Study
Biotherapy
A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients With Primary Melanoma
PLoS ONE
Multidisciplinary
Dose Efficacy Study of Two Schedules of High-Dose Bolus Administration of Interleukin 2 and Interferon Alpha in Metastatic Melanoma
British Journal of Cancer
Cancer Research
Oncology
